SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-314740
Filing Date
2022-12-29
Accepted
2022-12-29 16:04:53
Documents
2
Group Members
STEPSTONE GC GP, LLCSTEPSTONE INTERNATIONAL INVESTORS II, L.P.STEPSTONE INTERNATIONAL INVESTORS II-G, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d408900dsc13g.htm SC 13G 94359
2 EX-99.1 d408900dex991.htm EX-99.1 8638
  Complete submission text file 0001193125-22-314740.txt   104710
Mailing Address 4225 EXECUTIVE SQUARE SUITE 1600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 1600 LA JOLLA CA 92037 858-558-9700
StepStone Group LP (Filed by) CIK: 0001502287 (see all company filings)

IRS No.: 331156466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Subject) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88394 | Film No.: 221498879
SIC: 2834 Pharmaceutical Preparations